Detalles de la búsqueda
1.
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A.
Blood
; 128(5): 630-7, 2016 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27330001
2.
Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study.
Clin Appl Thromb Hemost
; 26: 1076029620950836, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32866032
3.
Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study.
Thromb Res
; 189: 96-101, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32197139
4.
Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.
Thromb Haemost
; 114(4): 676-84, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26293201
Resultados
1 -
4
de 4
1
Próxima >
>>